| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/08/2001 | WO2001016309A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | WO2001016306A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/08/2001 | WO2001016301A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | WO2001016300A2 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | WO2001016299A1 Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
| 03/08/2001 | WO2001016298A1 Cloning of mouse gpr10 receptor |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016295A1 Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons |
| 03/08/2001 | WO2001016294A2 Metal binding compounds and their use in cell culture medium compositions |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016289A2 Zymogen activation system |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016285A2 Novel proteases and variants thereof |
| 03/08/2001 | WO2001016182A2 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 03/08/2001 | WO2001016180A2 Cd40 agonist compositions and methods of use |
| 03/08/2001 | WO2001016179A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | WO2001016178A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 03/08/2001 | WO2001016175A1 A novel human rab gene and its coding polypeptide |
| 03/08/2001 | WO2001016173A1 fabF |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016169A2 RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE |
| 03/08/2001 | WO2001016168A2 Induction of programmed cell death by n5 gene |
| 03/08/2001 | WO2001016167A2 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 03/08/2001 | WO2001016166A2 Polypeptides, comprising il-6 ligand-binding receptor domains, and related nucleic acids, antibodies, compositions, and methods of use |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016164A2 Treatment of allergic rhinitis |
| 03/08/2001 | WO2001016163A2 Peptide mixture and vaccine against a chronic viral infection |
| 03/08/2001 | WO2001016158A2 Bridging integrator-2 (bin2) nucleic acid molecules and proteins and uses therefor |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016153A1 Cytomegalovirus-encoded il-10 homolog |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016093A1 SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 03/08/2001 | WO2001015752A1 Phospholipid-coated implants |
| 03/08/2001 | WO2001015741A2 Genetic suppressor elements against human immunodeficiency virus |
| 03/08/2001 | WO2001015739A1 Antisense modulation of human rho family gene expression |
| 03/08/2001 | WO2001015736A2 Interferon-beta conjugates |
| 03/08/2001 | WO2001015733A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 03/08/2001 | WO2001015732A1 Remedies for immunological diseases |
| 03/08/2001 | WO2001015730A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 03/08/2001 | WO2001015726A2 Compositions for stimulating cytokine secretion and inducing an immune response |
| 03/08/2001 | WO2001015724A1 Improved stable formulations of ace inhibitors, and methods for preparation thereof |
| 03/08/2001 | WO2001015723A1 Preventives or remedies for ischemic injury or ischemic reperfusion injury |
| 03/08/2001 | WO2001015722A2 Methods useful in affecting apoptosis |
| 03/08/2001 | WO2001015721A1 Novel uses of semaphorin and vegf |
| 03/08/2001 | WO2001015720A1 Methods and compositions for reducing serum phosphate levels |
| 03/08/2001 | WO2001015719A2 Treatment of conjunctivitis |
| 03/08/2001 | WO2001015711A1 Mineralized collagen membrane and method of making same |
| 03/08/2001 | WO2001015709A1 USE OF rAFP TO INHIBIT OR PREVENT APOPTOSIS |
| 03/08/2001 | WO2001015689A1 Use of amino acids for making medicines for treating to insulin-resistance |
| 03/08/2001 | WO2001015679A2 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015671A2 Flushable disposable polymeric products |
| 03/08/2001 | WO2001015666A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 03/08/2001 | WO2001015531A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | WO2001015511A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 03/08/2001 | WO2001000848A8 Useful polypeptide |
| 03/08/2001 | WO2000077184A9 Caspase-8 crystals, models and methods |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000066139A3 Biochemical methods that eliminate corneal scars, opacification and haze |
| 03/08/2001 | WO2000061766A3 Telomerase-specific cancer vaccine |
| 03/08/2001 | WO2000061624A8 48 human secreted proteins |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000057870A3 Viral treatment |
| 03/08/2001 | WO2000057861A3 Use of cytidine derivatives for the treatment of leukaemia |
| 03/08/2001 | WO2000057184A3 Screening methods based on fha domains |
| 03/08/2001 | WO2000054760A3 Bicyclo (3.3.1) nonenes useful for the treatment of diabetes and hypertriglyceridemia |
| 03/08/2001 | WO2000041546A9 Novel exendin agonist formulations and methods of administration thereof |
| 03/08/2001 | WO2000039290A3 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO2000026246A9 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 03/08/2001 | WO2000023588A8 G-protein coupled receptors |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO2000018961A3 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | DE19940227A1 Phospholipidgel Phospholipid |
| 03/08/2001 | DE19940012A1 Eukaryotic expression plasmid useful for treating peripheral arterial occlusive disease, comprises two expression cassettes, one containing the gene for human vascular endothelial growth factor VEGF165 |
| 03/08/2001 | CA2419618A1 Phospholipid-coated implants |
| 03/08/2001 | CA2403243A1 Nucleic acid based modulators of gene expression |
| 03/08/2001 | CA2388734A1 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | CA2387711A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383910A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | CA2383907A1 Human hydrolytic enzymes |
| 03/08/2001 | CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383773A1 Methods and compositions for treating autoimmune disease |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383606A1 Iren protein, its preparation and use |
| 03/08/2001 | CA2383603A1 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | CA2383601A1 Dna encoding the human serine protease eos |
| 03/08/2001 | CA2383519A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | CA2383460A1 Metal binding compounds and their use in cell culture medium compositions |